A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation

Immunity

Volumn 5, Issue 2, 1996, Pages 115-124

  Ossendorp, Ferry ^a   Eggers, Maren ^c   Neisig, Anne ^b   Ruppert, Thomas ^c   Groettrup, Marcus ^d   Sijts, Alice ^a   Mengedé, Erica ^a   Kloetzel, Peter M ^d   Neefjes, Jacques ^b   Koszinowski, Ulrich ^c   Melief, Cornelis ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; PROTEASOME;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; LEUKEMIA VIRUS; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 16044372545     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80488-4     Document Type: Article

References (46)

1. Androlewicz, M.J., Anderson, K.S., and Cresswell, P. (1993). Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner. Proc. Natl. Acad. Sci. USA 90, 9130-9134.
2. Boes, B., Hengel, H., Ruppert, T., Multhaup, G., Koszinowski, U.H., and Kloetzel P. M. (1994). Interferon γ stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasomes. J. Exp. Med. 179, 901-909.
3. Ciechanover, A. (1994). The ubiquitin-proteasome proteolytic pathway. Cell 79, 13-21.
4. De Campos-Lima, P.O., Levitsky, V., Brooks, J., Lee, S.P., Hu, L.F., Rickinson, A.B., and Masucci, M.G. (1994). T cell responses and virus evolution: loss of HLAA11 -restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues. J. Exp. Med. 179, 1297-1305.
5. Del Val, M., Schlicht, H.J., Ruppert, T., Reddehase, M.J., and Koszinowski, U.H. (1991). Efficient processing of an antigenic sequence for its presentation by MHC class I molecules depends on its neighboring residues in the protein. Cell 66, 1145-1153.
6. Dick, L.R., Aldrich, C., Jameson, S.C., Moomaw, C.R., Pramanik, B.C., Doyle, C.K., DeMartino, G.N., Sevan, M.J., Forman, J.M., and Slaughter, C.A. (1994). Proteolytic processing of ovalbumin and β-galactosidase by the proteasome to yield antigenic peptides. J. Immunol. 152, 3884-3894.
7. Eggers, M., Boes-Fabian, B., Ruppert, T., Kloetzel, P.-M., and Koszinowski, U.H. (1995). The cleavage preference of the proteasome governs the yield of antigenic peptides. J. Exp. Med., AU: in press.
8. Elliot, T., Willis, A., Cerundolo, V., and Townsend, A. (1995). Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum. J. Exp. Med. 181, 1481-1491.
9. Falk, K., Rötzschke, O., Stevanovic, S., Jung, G., and Rammensee, H.-G. (1991). Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351, 290-296.
10. Fehling, H.J., Swat, W., Laplace, C., Kühn, R., Rajewsky, K., Müller, U., and von Boehmer, H. (1994). MHC class I expression in mice lacking the proteasome subunit LMP-7. Science 265, 1234-1237.
11. Feltkamp, M.C.W., Smits, H.L., Vierboom, M.P.M., Minnaar, R.P., De Jongh, B.M., Drijfhout, J.W., Ter Schegget, J., Melief, C.J.M., and Kast, W.M. (1993). Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human Papillomavirus type 16-transformed cells. Eur. J. Immunol. 23, 2242-2249.
12. Gausepohl, H., Kraft, M., Boulin, C., and Frank, R.W. (1990) Automated multiple peptide synthesis with BOP activation. In Proceedings of the Eleventh American Peptide Symposium, J.E. Rivier and G. R. Marshall, eds. (ESCOM, Leiden), p. 1003.
13. Goldberg, A.L., and Rock, K.L. (1992). Proteolysis, proteasomes and antigen presentation. Nature 357, 9-23.
14. Groettrup, M., Ruppert, T., Kuehn, L., Seeger, M., Standera, S., Koszinowski, U., Kloetzel, P.-M. (1995). The interferon-γ inducible 11S regulator (PA28) and the LMP2/LMP7 subunits govern the peptide production by the 20S proteasome in vitro. J. Biol. Chem. 270, 23808-23815.
15. +subsets of T lymphocytes in monozygotic twins. J. Immunol. 150, 2033-2045.
16. Howard, J.C., and Seelig, A. (1993). Antigen processing: peptides and the proteasome. Nature 365, 211-212.
17. Hughes, E.A., Ortmann, B., Surman, M., and Cresswell, P. (1996). The protease inhibitor, N-acetyl-L-leucyl-L-leucyl-L-norleucinal, decreases the pool of major histocompatibility complex class I-binding peptides and inhibits peptide trimming in the endoplasmic reticulum. J. Exp. Med. 183, 1569-1578.
18. Löwe, J., Stock, D., Jap, B., Zwickl, P., Baumeister, W., and Huber, R. (1995). Crystal structure of the 20S proteasome from the archaon T. acidophilum at 3.4 Å resolution. Science 268, 533-539.
19. Ljunggren, H.-G., and Kärre, K. (1985). Host resistance directed selectively against H-2 deficient lymphoma variants. J. Exp. Med 162, 1745-1759.
20. Melief, C.J.M. (1992). Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. Adv. Cancer Res. 58, 143-175.
21. Momburg, F.M., Roelse, J., Hämmerling, G.J., and Neefjes, J.J. (1994a). Peptide size selection by the MHC-encoded peptide transporter. J. Exp. Med. 179, 1613-1623.
22. Momburg, F., Roelse, J., Howard, J.C., Butcher, G.W., Hämmerling, G.J., and Neefjes, J.J. (1994b). Selectivity of MHC-encoded peptide transporters from human, mouse and rat. Nature 367, 648-651.
23. Neefjes, J.J., Momburg, F., and Hämmerling, G.J. (1993). Selective and ATP-dependent translocation by the MHC-encoded transporter. Science 261, 769-771.
24. Neisig, A., Roelse, J., Sijts, A.J.A.M., Ossendorp, F., Feltkamp, M.C.W., Kast, W.M., Melief, C.J.M., and Neefjes, J.J. (1995). Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences. J. Immunol. 154, 1273-1279.
25. Niedermann, G., Butz, S., Ihlenfeld, H.G., Grimm, R., Lucchiari, Hoschützky, H., Jung, G., Maier, B., and Eichmann, K. (1995). Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. Immunity 2, 289-299.
26. Orlowski, M., Cardozo, C., and Michaud, C. (1993). Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex: properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids. Biochemistry 32, 1563-1572.
27. b haplotype reveal genetic control of isotype expression. J. Immunol. 126, 317-321.
28. Phillips, R.E., Rowland-Jones, S., Nixon, D.F., Gotch, F.M., Edwards, J.P., Ogunlesi, A.O., Elvin, J.G., Rothbard, J.A., Bangham, C.R.M., Rizza, C.R., and McMichael, A.J. (1991). Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354, 453-459.
29. Plata, F., and Lilly, F. (1979). Viral specificity of H-2 restricted T killer cells directed against syngeneic tumors induced by Gross, Friend, or Rauscher leukemia virus. J. Exp. Med. 150, 1174-1186.
30. Roelse, J., Grommé, M., Momburg, F., Hämmerling, G., and Neefjes, J. (1994). Trimming of TAP-translocated peptides in the endoplasmic reticulum and in the cytosol during recycling. J. Exp. Med. 180, 1591-1597.
31. Rock, K.L., Gramm, G., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., and Goldberg, A.L. (1994). Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78, 761-771.
32. Schumacher, T.N.M., Kantesaria, D.V., Heemels, M.T., Ashton-Rickardt, P.G., Shepherd, J.C., Fruh, K., Yang, Y., Peterson, P.A., Tonegawa, S, and Ploegh, H.L. (1994). Peptide length and sequence specificity of the mouse TAP1/TAP2 translocator. J. Exp. Med. 179, 533-540.
33. Shepherd, J.C., Schumacher, T.N.M., Ashton-Rickardt, P.G., Imaeda, S., Ploegh, H.L., Janeway, C.A., Jr., and Tonegawa, S. (1993). TAP1 -dependent peptide translocation in vitro is ATP-dependent and peptide selective. Cell 74, 577-584.
34. Shinnick, T.M., Lerner, R.A., and Sutcliffe, J.C. (1981). Nucleotide sequence of Moloney murine leukemia virus. Nature 293, 534-548.
35. Sijts, A.J.A.M., Ossendorp, F., Mengedé, E.A.M., van den Elsen, P.J., and Melief, C.J.M. (1994a). Immunodominant mink cell focus-inducing murine leukemia virus (MuLV)-encoded CTL epitope, identified by its MHC class I binding motif, explains MuLV-type specificity of MCF-directed cytotoxic T lymphocytes. J. Immunol. 152, 106-116.
36. b mutant bm13 mice. J. Virol. 68, 6038-6046.
37. Sijts, A.J.A.M., Leupers, C.J.M., Mengedé, E.A.M., Loenen, W.A.M., Van den Elsen, P.J., and Melief, C.J.M. (1994c). Cloning of the MCF 1233 murine leukemia virus and identification of sequences involved in viral tropism, oncogenicity and T cell epitope formation. Virus Res. 34, 339-349.
38. Snyder, H.L., Yewdell, J.W., and Bennink, J.R. (1994). Trimming of antigenic peptides in an early secretory compartment. J. Exp. Med. 180, 2389-2394.
39. Van Binnendijk, R.S., Van Baalen, C.A., Poelen, M.C.M., De Vries, P., Boes, J., Cerundulo, V., Osterhaus, A.D.M.E., and Uytenhaag, F.G.C.M. (1992). Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognition. J. Exp. Med. 176, 119-128.
40. Van der Burg, S.H., Visseren, M.J.W., Brandt, R.M.P., Kast, W.M., and Melief, C.J.M. (1996). Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability. J. Immunol. 156, 3308-3314.
41. Van Kaer, L., Ashton-Rickardt, P.G., Eichelberger, M., Gaczynska, M., Nagashima, K., Rock, K.L., Goldberg, A.L., Doherty, P.C., and Tonegawa, S. (1994). Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity 1, 533-541.
42. Vasmel, W.L.E., Zijlstra, M., Radaszkiewicz, T., Leupers, C.J.M., De Goede, R.E.Y., and Melief, C.J.M. (1988). Major histocompatibility complex class II-regulated immunity to murine leukemia virus protects against early T- but not late B-cell lymphomas. J. Virol. 62, 3156-3166.
43. b-restricted peptide from the p15E transmembrane protein of endogenous ecotropic murine leukemia virus (MuLV) AKR 623 that restores susceptibility of a tumor line to anti-AKR/Gross MuLV cytotoxic T lymphocytes. J. Virol. 68, 897-904.
44. Wiertz, E.J.H.J., Jones, T.R., Sun, L., Bogyo, M., Geuze, H.J., and Ploegh, H.L. (1996). The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84, 769-779.
45. Zijlstra, M., and Melief, C.J. M. (1986). Virology, genetics and immunology of murine lymphomagenesis. Biochim. Biophys. Acta 865, 197-231.
46. Zijlstra, M., De Goede, R.E.Y., Schoenmakers, H.J., Schinkel, A.H., Hesselink, W.G., Portis, J.L., and Melief, C.J.M. (1983). Naturally occuring leukemia viruses in H-2 congenic C57BL mice. III Characterization of C-type viruses isolated from lymphomas induced by milk transmission of B-ecotropic virus. Virology 125, 47-63.